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Dengue virus (DENV) is an enveloped ﬂavivirus with a positive-sense RNA genome transmitted by
Aedes mosquitoes, causing the most important arthropod-borne viral disease affecting humans.
Relatively few cis-acting RNA regulatory elements have been described in the DENV coding-region.
Here, by introducing silent mutations into a DENV-2 infectious clone, we identify the conserved capsid-
coding region 1 (CCR1), an RNA sequence element that regulates viral replication in mammalian cells
and to a greater extent in Ae. albopictus mosquito cells. These defects were conﬁrmed in vivo, resulting
in decreased replication in Ae. aegypti mosquito bodies and dissemination to the salivary glands.
Furthermore, CCR1 does not regulate translation, RNA synthesis or virion retention but likely modulates
assembly, as mutations resulted in the release of non-infectious viral particles from both cell types.
Understanding the role of CCR1 could help characterize the poorly-deﬁned stage of assembly in the
DENV life cycle and uncover novel anti-viral targets.
& 2012 Elsevier Inc. All rights reserved.Introduction
Dengue is caused by four distinct dengue virus serotypes
(DENV1–4), which are transmitted by the Aedes aegypti and Ae.
albopictus mosquitoes, and is the most prevalent arthropod-borne
viral illness affecting humans (Gubler, 2002b). DENV is a member of
the family Flaviviridae, which includes other major public health
concerns such as yellow fever virus, hepatitis C virus and West Nile
virus (Burke and Monath, 2001; Gubler, 2002a). DENV causes a
spectrum of clinical disease, with an estimated 40 million cases of
dengue fever (DF) and 250,000–500,000 cases of the more severe
forms of the illness, dengue hemorrhagic fever (DHF) and dengue
shock syndrome (DSS) annually (Kyle and Harris, 2008). Based on
vector distribution, approximately 3 billion of the world’s population
is at risk for DENV infection as a result of human population growth,
increased urbanization, and greater ease in international shipping and
travel (Gubler, 1998, 2002b; Kyle and Harris, 2008; Rosen, 1977).
Currently, there are no effective antiviral therapies or vaccines
available for dengue and treatment is largely supportive; thus,ll rights reserved.
s and Vaccinology, School of
ersity of California, Berkeley
.controlling the mosquito population in order to reduce transmission
is our best defense.
DENV is a small (40 nm), enveloped RNA virus with a positive-
sense RNA genome of 11 kilobases that encodes 10 viral proteins
in a single open reading frame (ORF) (Clyde et al., 2006). The
genome contains a 50 type 1 7-methyl-G cap and an ORF that is
ﬂanked by highly structured 50 and 30 untranslated regions (UTRs),
and it lacks a poly(A) tail (Chambers et al., 1990; Lindenbach et al.,
2007). The ORF is translated as a single polyprotein that is cleaved
co- and post-translationally by both viral and host proteases (Arias
et al., 1993). The viral genome encodes three structural proteins
(C, prM/M and E) and seven nonstructural (NS) proteins (NS1, NS2A/
B, NS3, NS4A/B and NS5). As with other positive-sense RNA viruses,
the 50 and 30 UTRs contain several conserved cis-acting RNA
elements that play key roles in regulating viral translation and
RNA synthesis (Lindenbach et al., 2007).
The fully assembled ﬂavivirus virion consists of a nucleocapsid
core containing the viral RNA (vRNA), surrounded by a lipid
bilayer derived from the endoplasmic recticulum (ER), which
includes the viral E and prM/M proteins (Lindenbach et al.,
2007). Flavivirus virions are assembled in association with intra-
cellular membranes (Murphy, 1980) and are ﬁrst observed in the
ER lumen in vitro (Hase et al., 1987a; Ishak et al., 1988; Ko et al.,
1979; Leary and Blair, 1980; Matsumara et al., 1977; Ng, 1987;
Ohyama et al., 1977; Sriurairatna and Bhamarapravati, 1977) and
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while virions accumulate within membrane-bound vesicles, clear
budding intermediates and naked nucleocapsids have not been
observed (Alvisi et al., 2011; Welsch et al., 2009), which suggests
that viral assembly is rapid. Viral assembly is localized to the
membranous sites of replication by the hydrophobic segments of
the anchored C protein (Nowak et al., 1989), and nucleocapsids
acquire an envelope by budding into the ER lumen. The viral NS3
protein has been implicated in intracellular trafﬁcking of the
progeny non-infectious virions from the ER through the Golgi
compartment (Chua et al., 2004). During virion maturation in the
trans Golgi compartment, the prM protein is processed to the
mature M protein by the host protease furin, which exposes the E
receptor-binding domain that confers viral infectivity (Stadler
et al., 1997; Zybert et al., 2008). Intracellular M-containing virions
have not been detected, suggesting that prM cleavage occurs just
before the release of mature virions (Lindenbach et al., 2007;
Nelson et al., 2008; Yu et al., 2009). Virion transport from the sites
of replication to the cell surface involves vesicles derived from the
ER (Deubel and Digoutte, 1981) and other components of the
exocytic pathway (Hase et al., 1987a; Heinz et al., 1994;
Sriurairatna and Bhamarapravati, 1977). Recently, it has been
shown that the DEAD-box RNA helicase DDX6 interacts with the
DENV2 vRNA in vitro and in vivo via binding to the dumbbell (DB)
structures 1 and 2 in the 30 UTR, modulating the production of
infectious viral particles (Ward et al., 2011). It is likely that DDX6
and other stress granule (SG) proteins recruit the vRNA to the P
body and SG sites of assembly through their interaction with the
30 UTR (Ward et al., 2011). Despite the information available on
viral assembly, the mechanism by which the vRNA is recognized
by the capsid protein to form the nucleocapsid precursor is still
unknown. Thus far, no candidate assembly signals have been
identiﬁed within the DENV genome, and the ability of subge-
nomic replicons lacking the majority of the structural protein-
coding sequence to be assembled in trans (Jones et al., 2005;
Khromykh et al., 1998) suggests that the signal does not reside in
the prM/M/E region of the genome.
Much of what is known about RNA elements located in the
UTRs has been shown to be equally important for viral replication
in mammalian cells and mosquito cells, with a few exceptions.
Deleting the variable region (VR) within the 30 UTR reduces RNA
synthesis in the mammalian baby hamster kidney cell line (BHK)
but slightly ampliﬁes RNA synthesis in an Ae. albopictus mosquito
cell line(C6/36) (Alvarez et al., 2005a). On the other hand, changes
to the bottom stem structure of the 30 stem-loop (SL), located at
the 30 end of the viral genome, were shown to have wild-type
(WT) replication levels in BHK cells but not in C6/36 cells (Zeng
et al., 1998). To date, these are the only regions within the DENV
genome that display cell type-associated differential effects on
the viral life cycle, likely due to interactions with host-dependent
factors. Indeed, identifying host-speciﬁc protein interactions is
vital for understanding how the virus differentially modulates its
life cycle in the human host and the mosquito vector.
Little information is available with respect to cis-acting RNA
regulatory elements located within the DENV coding-region, as
compared to those located within the 50 and 30 UTRs. Previous
studies have shown that the 50 conserved sequence (CS), found
within the capsid-coding sequence, regulates RNA synthesis
through interaction with the complementary 30 CS, located within
the 30 UTR (Chiu et al., 2005; Khromykh et al., 2001). Recently,
another set of complementary sequences, termed the down-
stream AUG region (DAR) was identiﬁed, with the 50 DAR located
just downstream of the initiating AUG and the complementary 30
DAR sequence found in the 30 UTR (Friebe and Harris, 2010; Friebe
et al., 2011). The 50/30 DAR acts together with the 50/30 CS and 50/30
upstream AUG region (UAR), another pair of complementarysequences, to circularize the viral genome, which is a requirement
for efﬁcient RNA synthesis but is not involved in viral translation
(Alvarez et al., 2005b, 2008; Friebe and Harris, 2010; Friebe et al.,
2011; Khromykh et al., 2001). Additionally, a cis-acting RNA
secondary structure, termed the capsid-coding hairpin (cHP),
was recently found to regulate both viral translation and RNA
synthesis in mammalian and mosquito cells (Clyde et al., 2008;
Clyde and Harris, 2006). Based on the structure prediction algo-
rithms that have been published, the DENV coding sequence has
been reported to be rather unstructured (Hofacker et al., 1994;
Thurner et al., 2004), though no functional proof exists that the
coding-region lacks conserved cis-acting RNA sequence elements.
While none have been identiﬁed yet in DENV, coding-region
cis-acting RNA regulatory elements have been found in a number
of animal and plant viruses, modulating various aspects of the
viral life cycle besides viral translation and RNA synthesis. These
include trafﬁcking of the vRNA to the membranous sites of
replication, viral assembly, and other less well-characterized
steps in viral replication (Liu et al., 2009; Miller and White,
2006). Speciﬁcally, in the cucumber necrosis tombusvirus,
recruitment of the positive- and negative-strand vRNA to perox-
isomal membranes is mediated via binding of a viral protein to a
coding-region cis-acting RNA element (Panavas et al., 2005). In
ﬂock house viruses, an RNA structural element in RNA1 is
predicted to form two stem-loops with nearly identical sequences
that are required both for the recruitment of RNA1 to the outer
mitochondrial membranes and for positive- and negative-strand
RNA synthesis (Van Wynsberghe and Ahlguist, 2009). In Sindbis
virus, a 132 nucleotide-long segment of the nsp1-coding
sequence is predicted to form four stem loop structures (Frolova
et al., 1997; Linger et al., 2004; Weiss et al., 1994), two of which
were found to be essential for vRNA encapsidation (Linger et al.,
2004). In the ORF1b of group 2 corona mouse hepatitis virus, a 69-
nucleotide bulged stem-loop is required for viral packaging
(Fosmire et al., 1992), whereas in nodaviruses, the packaging
signal for RNA2 is located within a 32-nucleotide region of RNA2
(Zhong et al., 1992).
This study sought to identify additional cis-acting RNA reg-
ulatory elements in the DENV coding region in order to expand
our knowledge of how the viral life cycle is regulated. We
describe a novel coding-region cis-acting RNA regulatory element
termed the conserved capsid-coding region 1 (CCR1), which
regulates the viral life cycle in both mammalian and mosquito
cells, though it displays a more prominent role in mosquito cells.
Consistent with our in vitro data, CCR1 mutant viruses do not
replicate as well as WT DENV-2 in Ae. aegypti mosquitoes,
resulting in a reduction of viral transmission to the salivary
glands. We demonstrate that CCR1 plays a role in post-RNA
replication events, possibly acting as an assembly signal for DENV
in a sequence-dependent and cell type-speciﬁc manner. These
studies are important for improving our understanding of cis-
acting determinants that differentially regulate the viral life cycle
in the human host and mosquito vector, potentially serving in the
design of attenuated vaccine strains or as targets for novel
antiviral agents.Results
A novel RNA element is predicted to be conserved both in sequence
and secondary structure in the DENV and TBE serogroups
Selection of conserved coding-region RNA elements was based
on an alignment of sequences from the representative genomes of
DENV1–4, generated using Clustal W2 (Thompson et al., 1997).
Conserved RNA sequence elements were identiﬁed by comparing
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surrounding sequences, which was deﬁned as 30 nucleotides
upstream and downstream of the uncharacterized element,
requiring at least 70% homology in the region of interest. The
sequence alignment for DENV1–4 revealed a short stretch of
sequence in the capsid gene that contains a greater degree of
sequence homology (89%) than that of the surrounding
sequences (64%) (Fig. 1A). The same stretch of sequence was
identiﬁed in the tick-borne encephalitis (TBE) serogroup align-
ment (100% homology vs. 65% background) (Fig. 1C); however, the
sequence was not well-conserved in the Japanese encephalitis
virus (JEV) serogroup (44% homology vs. 32% background, Fig. 1B).Fig. 1. Conserved RNA elements are identiﬁed in the capsid coding-region of the DENV
(A) DENV serogroup (nucleotides 118–177, numbering based on DENV2 Thai strain 16
DENV4 GU289913), (B) JEV serogroup (nucleotides 120–179, numbering based on JEV
NC_001563, Kunjin virus AY274505, St. Louis encephalitis virus DQ525916 and YFV U1
Omsk hemorrhagic fever viruses (nucleotides 121–180, numbering based on TBEV; acce
using Clustal W2 (Thompson et al., 1997). Positions of sequence homology are indicat
initiator AUG is underlined in the TBE serogroup. The conserved RNA sequence ele
(nucleotides 1–274, numbering based on DENV2 Thai strain 16681), (E) JEV (nucleoti
numbering based on TBEV) as computed by RNAalifold (Hofacker et al., 2002), where cov
CCR2, CCR3 and other major known RNA elements, such as cHP and SLA, are indicatedBased on this high level of sequence conservation in the DENV
and TBE serogroups, the RNA sequence element was termed the
conserved capsid-coding region 1 (CCR1).
The DENV, JEV and TBE serogroup alignments were modiﬁed
so as to include the 50 UTR as well as a large portion of the capsid-
coding region to generate phylogenetically-conserved structure
predictions using RNAalifold (Hofacker et al., 2002). The conserved
RNA element CCR1 was found to be contained entirely within a
small hairpin structure that is maintained by covariation in both
the DENV and TBE serogroups (Fig. 1D and F) but not in the JEV
serogroup (Fig. 1E). Though the CCR1 sequence and structure
has not yet been identiﬁed in DENV, a homolog was recently, JEV and TBE serogroups. Partial alignment of the representative genomes for the
681; accession codes DENV1 U88535, DENV2 NC_001474, DENV3 AY099336 and
; accession codes JEV M18370, Murray Valley encephalitis virus AF161266, WNV
7067) and (C) TBE serogroup, including the tick-borne encephalitis, Powassan and
ssion codes TBEV U27495, Powassan NC_003687 and Omsk AY193805), generated
ed by asterisks; the 50 CS is underlined in the DENV and JEV serogroups; and the
ment CCR1 is boxed. Phylogenetic consensus structure based on the (D) DENV
des 1–273, numbering based on JEV) and (F) TBE serogroups (nucleotides 1–302,
ariance is depicted as a colored spectrum ranging from purple (0) to red (1). CCR1,
. The initiator AUG is circled.
Fig. 2. Conserved RNA structure elements in the context of a circularized DENV genome. Phylogenetic consensus structure based on the representative genomes for the
DENV serogroup (position 1–417 and 9341–10723, numbering based on DENV2 Thai strain 16681; accession codes DENV1 U88535, DENV2 NC_001474, DENV3 AY099336
and DENV4 GU289913) as computed by RNAalifold (Hofacker et al., 2002), where covariance is depicted as circles. DENV serogrup alignment included the 50 and 30 UTRs,
the entire capsid-coding sequence (nts 97–438) and a large portion of the NS5-coding region (nts 9341–10269). CCR1, CCR2, CCR3 and other major known RNA elements,
such as cHP, SLA, 30 SL, 50/30 UAR, 50/30 DAR, and 50/30 CS are indicated.
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shown to be important for efﬁcient viral translation, acting either
directly or indirectly as a determinant of RNA replication in a
manner proportional to its stability (Rouha et al., 2011). Our
secondary structure predictions both conﬁrm their results (Rouha
et al., 2011) and demonstrate that CCR1 is a highly conserved
nucleotide sequence and structural element in the TBE serogroup
as well (Fig. 1C and F) though its role in the DENV life cycle has
not yet been elucidated.
Since it is known that the DENV genome circularizes during
viral replication, we created a modiﬁed DENV1–4 sequence
alignment that included the 50 and 30 UTRs, the entire capsid-
coding sequence and a large portion of the NS5-coding region,
which was analyzed using RNalifold (Hofacker et al., 2002),
demonstrating the predicted phylogenetic consensus structure
for the DENV serogroup during viral replication where the ends of
the genome basepair via the three sets of complementary
sequences (50/30 CS, 50/30 UAR and 50/30 DAR) (Fig. 2). In addition
to illustrating known cis-acting RNA structural elements such as
SLA and cHP, CCR1 was easily identiﬁable (Fig. 2), conﬁrming the
results obtained in the previous analysis (Fig. 1D). However, while
the predicted secondary structure of CCR1 shows a high degree of
covariance, it is not as highly conserved as the predicted second-
ary structures of other known elements such as the SLA or cHP
(Fig. 1D, F and Fig. 2), indicating that the predicted secondary
structure of CCR1 may not be as important as the primary
nucleotide sequence.
Interestingly, both the larger circularized structure prediction
and the smaller conserved structure predictions showed that
there were two additional conserved RNA structural elements in
the DENV capsid-coding region, termed conserved capsid-coding
region 2 (CCR2) and CCR3 (Figs. 1D and 2), which were both found
to be conserved among members of the JEV (Fig. 1E) and TBE
(Fig. 1F) serogroups. Much like the cHP, the primary nucleotidesequence of CCR2 and CCR3 is not well-conserved in the DENV,
JEV and TBE serogroups, despite the fact that the predicted
secondary structures are conserved (data not shown). Recently,
a homolog of CCR3 was identiﬁed in TBE virus, termed stem-loop
6 (SL6), which was shown to act as a structural element that is not
essential for growth in tissue culture but functions as a replication
enhancer (Tuplin et al., 2011). Taken together, it is likely that
CCR1, CCR2 and CCR3 are conserved in sequence and/or second-
ary structure because they play a putative role in modulating the
viral life cycle.
CCR1 modulates the viral life cycle in both BHK and C6/36 cells
To determine whether CCR1 regulates viral replication, silent
point mutations were introduced into an infectious clone of the
DENV2 Thai strain 16681, termed pD2/IC (Kinney et al., 1997). To
disrupt the predicted secondary structure with minimal changes
to the primary nucleotide sequence, two silent nucleotide
changes were introduced into either side of the predicted stem
structure (‘‘50/30 ﬂank mut,’’ Fig. 3A and Table 1), which linearized
the stem-loop and eliminated competing structure predictions in
the mfold prediction software (Zuker, 2003). Next, the primary
nucleotide sequence was mutated without affecting the predicted
secondary structure by introducing six silent nucleotide changes
into CCR1 (‘‘seq mut,’’ Fig. 3A and Table 1) in such a way that the
predicted free energy is similar to that of the wild-type (WT).
Thus, despite minor changes to the stem, the overall structure of
CCR1 is maintained in this mutant construct, as predicted by
mfold (Zuker, 2003). A third mutant, termed the ‘‘center mut’’
construct, contains only the nucleotide changes that were intro-
duced in the predicted loop of the ‘‘seq mut’’ construct (Fig. 3A
and Table 1).
Adjacent to CCR1 is the stem structure CCR2, which was
predicted to act as a structural element given the lack of
Fig. 3. Mutational analysis of CCR1, CCR2 and CCR3 in order to examine their putative role as cis-acting RNA regulatory elements. (A) mfold predictions of the mutant
constructs designed to disrupt the primary nucleotide sequence (‘‘seq mut’’) or the predicted secondary structure (‘‘50/30 ﬂank mut’’). The sequence changes introduced into
the predicted loop region of the ‘‘seq mut’’ construct were isolated in the ‘‘center mut’’ without altering the predicted secondary structure of CCR1 as predicted by mfold
(Zuker, 2003). An additional sequence mutant was generated (‘‘seq mut v2’’), which oscillates between a linear conformation an alternative stem structure that is less
stable than the WT. mfold predictions (Zuker, 2003) of the mutant constructs designed to disrupt the predicted secondary structures of conserved RNA structural elements
(B) CCR2 and (C) CCR3. The predicted stem-loop of CCR2 was disrupted with conserved amino acid changes (‘‘CCR2aa mut’’). The predicted stem-loop structure of CCR3
was disrupted with silent point mutations (‘‘CCR3sil mut’’ and ‘‘CCR3sil mut v2’’). The positions of introduced mutations are indicated by boxes.
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pin structure of CCR2, ten mutations were introduced into the
stem, though these sequence alterations also introduced con-
served amino acid changes (‘‘CCR2aa mut,’’ Fig. 3B and Table 1).
Since CCR2 is directly downstream of CCR1, the mutant construct
was designed so that the mutations would not affect neighboring
RNA elements while still stably disrupting the CCR2 stem-struc-
ture as predicted by mfold (Zuker, 2003) (Fig. 3B). To disrupt the
predicted secondary structure of CCR3 with minimal changes to
the primary nucleotide sequence, a series of silent sequence
changes were introduced into either side of the predicted stem
structure (‘‘CCR3sil mut’’ and ‘‘CCR3sil mut v2,’’ Fig. 3C and
Table 1). For all mutant constructs designed, reading frame and
codon usage bias in baby hamster kidney (BHK) and Ae. albopictus
mosquito (C6/36) cells were maintained while preserving the
surrounding secondary structures as predicted by the mfold(Zuker, 2003). Unless otherwise indicated, amino acid sequence
was also maintained in all mutant constructs, and codon usage
bias was taken into account to ensure that the mutated codon was
equally available in both BHK and C6/36 cells.
RNA transcripts were transfected into BHK or C6/36 cell
monolayers, and virus-containing supernatants were harvested
at various timepoints (indicated as hours post-transfection, hpt)
to be assayed for viral infectivity via plaque assays. As DENV
replication kinetics are slower in C6/36 cells, virus-containing
supernatants were assayed for viral infectivity at later times post-
transfection than in BHK cells (BHK: 24, 48 and 72 hpt; C6/36: 72,
96, 120 and 144 hpt). Interestingly, all mutant CCR1 constructs
(‘‘50/30 ﬂank mut,’’ ‘‘center mut,’’ and ‘‘seq mut’’) demonstrated a
signiﬁcantly smaller plaque phenotype (see representative image
from ‘‘seq mut’’ in Fig. 4A), but only the mutations that disrupted
the primary nucleotide sequence (‘‘seq mut’’) rather than the
Table 1
Sequence of WT, CCR1, CCR2 and CCR3 mutants.
Construct Nucleotide sequence Amino acid sequence
WT 50–AAACGCGAGAGAAACCGCGTG–30
50/30 ﬂank mut 50–AAACGaGAGAGAAACCGaGTG–30
seq mut 50–AAACGaGAacGgAAtCGtGTG–30
center mut 50–AAACGCGAacGgAACCGCGTG–30
seq mut v2 50–AAgaGgGAacGtAAtaGaGTG–30
WT 50–GTGTCGACTGTGCAACAGCTGACAAAG-30 50–VSTVQQLTK-30
CCR2aa mut 50-GTGaCctCcGTGCAAaAcaTctCcAAG-30 50–VTSVQNISK-30
WT 50–CTTGGAATGCTGCAGGGACGAGGACCATTA
AAACTGTTCATGGCCCTGGTGGCGTTCCTT–30
CCR3sil mut 50-CTTGGAATGCTGCAGGGACGAGGACCAcTc
AAACTGTTCATGGCgCTGGTcGCGTTCCTT-30
CCR3sil mut v2 50-CTTGGAATGCTGCAGGGAaGAGGcCCAcTgAA
gCTGTTtATGGCttTGGTaGCtTTCCTT-30
Amino acid changes are underlined where applicable.
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reduced the viral titer in BHK cells at all timepoints tested
(Fig. 4B). Since the primary nucleotide sequence of CCR1 is
important in BHK cells, an additional mutant construct was
designed with nine silent sequence changes, termed ‘‘seq mut
v2’’ (Fig. 3A and Table 1). Unlike the other CCR1 mutant con-
structs, the ‘‘seq mut v2’’ mfold structure prediction oscillates
between a linearized form and a short hairpin structure, though
the altered stem-structure is predicted to be less stable than the
WT (Fig. 3A). When transfected into BHK cells, both sequence
mutants (‘‘seq mut’’ and ‘‘seq mut v2’’) displayed a no-plaque
phenotype at 24 hpt, and at later timepoints both showed a
signiﬁcantly lower viral titer in comparison to the WT (Fig. 4B).
While the ‘‘seq mut’’ construct showed a small plaque phenotype,
the ‘‘seq mut v2’’ construct demonstrated a signiﬁcantly extra
small plaque phenotype (see representative image from ‘‘seq mut
v2’’ in Fig. 4A) at all timepoints yielding detectable virus. Altering
the primary nucleotide sequence decreased viral titer in BHK
cells, and this effect was inﬂuenced in part by the central
sequences since the ‘‘center mut’’ construct had a signiﬁcantly
lower viral titer in comparison to the WT at all timepoints tested
(Fig. 4B).
In contrast to BHK cells, changes to the primary nucleotide
sequence (‘‘seq mut’’ and ‘‘seq mut v2’’) as well as changes to the
predicted secondary structure (‘‘50/30 ﬂank mut’’) signiﬁcantly
decreased the viral titer in C6/36 cells at all timepoints tested
(Fig. 4C). The ‘‘seq mut’’ construct did not result in any infectious
virus at early timepoints, and viral titers barely exceeded the limit
of detection at later times post-transfection, while the ‘‘seq mut
v2’’ construct maintained a no-plaque phenotype at all timepoints
tested (Fig. 4C). Unlike in BHK cells, the effect on viral titer in C6/
36 cells appears to be primarily mediated by the 50 and 30 ﬂanking
sequences since the ‘‘center mut’’ construct had slightly higher
titers at later timepoints than the ‘‘50/30 ﬂank mut’’ construct,
although the ‘‘center mut’’ construct displayed a signiﬁcantly
lower titer than the WT at all timepoints tested (Fig. 4C). In
transfected C6/36 cells, all mutant constructs tested that pro-
duced detectable infectious virus displayed a small plaque phe-
notype (Fig. 4A). It is known that not all dengue viruses form
plaques, and it is conceivable that the CCR1 mutant viruses may
form diffuse plaques that are not easily detected using standard
plaque assays. In order to conﬁrm that plaque assays are a viable
means of assessing infectivity of the mutant viruses, the virus-
containing supernatants from IC-transfected BHK and C6/36 cells
were also assessed for viral infectivity using an immunofocus
assay as an alternative measure of infectivity that does not
depend on plaque formation. The results from the immunofocusassays conﬁrmed the plaque assay results (data not shown),
demonstrating that mutations to CCR1 alter infectious particle
production in both BHK and C6/36 cells.
Though the changes that were introduced into CCR1 are not
predicted to have an effect on neighboring RNA elements, it was
important to demonstrate that these sequence and structural
changes would not disrupt the function of the cHP element, which
has been shown to regulate start site selection in BHK and C6/36
cells (Clyde et al., 2008; Clyde and Harris, 2006). To this end, the
mutations in the ‘‘50/30 ﬂank mut,’’ the ‘‘seq mut’’ and the ‘‘seq
mut v2’’ constructs were subcloned into the C-FLAG reporter that
had been previously constructed to visualize the full-length
capsid protein and the two truncated capsid proteins generated
by alternate start codon usage (Clyde and Harris, 2006). As
expected, the WT and mutant CCR1 C-FLAG reporter constructs
continued to favor translation of full length capsid protein (Fig.
S1), in contrast to a mutant cHP construct (HP0.2), which had
been previously shown to favor selection of the second AUG start
codon in BHK or C6/36 cells (Clyde and Harris, 2006). These data
also demonstrate that the CCR1 element itself plays no role in
start site selection and has a function distinct from the cHP. Taken
together, these results indicate that CCR1 functions primarily as a
cis-acting RNA sequence element in both BHK and C6/36 cells,
though these effects are more dramatic in C6/36 cells. Further-
more, the structure of CCR1 may also be required for efﬁcient
replication in C6/36 cells since the ‘‘50/30 ﬂank mut’’ construct did
not replicate as well as the ‘‘center mut’’ construct, which
contains a WT stem-structure (Fig. 4C).
Preliminary analysis of CCR2 and CCR3 indicated that the
predicted secondary structures of CCR2 and CCR3 are not critical
for the viral life cycle in BHK cells since the mutant constructs
replicated as well as the WT at 72 hpt (Fig. 4D). The ‘‘CCR2aa mut’’
mutant replication levels also imply that this region is not
sensitive to amino acid changes (Fig. 4D). Taken together, though
their stem-structures are well conserved, neither CCR2 nor CCR3
appear to be critical cis-acting RNA regulatory elements in BHK
cells. Because the effect of mutations in CCR2 and CCR3 were
minimal compared to CCR1, these regions were not pursued
further.
Altering CCR1 impairs viral replication in Ae. aegypti mosquitoes
Since changes to the CCR1 primary nucleotide sequence were
shown to have more dramatic effects in mosquito cells (Fig. 4C),
Ae. aegypti mosquitoes were infected with the various CCR1
mutant viruses to determine whether the results obtained in
the in vitro experiments could be observed in an in vivo model of
Fig. 4. CCR1 acts as a cis-acting RNA sequence element in modulating the viral life cycle in BHK and C6/36 cells. (A) Plaque phenotype in BHK cells obtained by transfecting
BHK or C6/36 cell monolayers with the described mutant constructs (SP, small plaque; ESP, extra small plaque). Left panel: A representative image for SP generated from
‘‘seq mut’’ construct in IC-transfected BHK cells and a representative image for ESP generated from ‘‘seq mut v2’’ construct in IC-transfected BHK cells. Right panel: Plaques
were measured (millimeters, mm) for each described plaque phenotype using 60 plaques from 3 independent experiments. (B) BHK and (C) C6/36 cells were transfected
with IC-based mutant CCR1 constructs and assayed for viral titer (pfu/mL) by plaque assay. Viral titers were normalized to the amount of vRNA present in the cells at the
time of harvest as measured by qRT-PCR. Results were obtained from 5 independent experiments, conducted in duplicate. Plaque phenotypes are indicated for each
construct. (D) BHK cells were transfected with IC-based mutant CCR2 and CCR3 constructs and assayed for viral titer (pfu/mL) by plaque assay at 72 hpt. Viral titers were
normalized to the amount of vRNA present in the cells at the time of harvest as measured by qRT-PCR. Results were obtained from 3 independent experiments, conducted
in duplicate. The limit of detection is shown by a dashed line (1.9 pfu/mL). *po0.05 relative to the WT. **po0.05 relative to the SP. Error bars indicate standard deviation.
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pods depends on ingesting a blood meal that contains sufﬁcient
virus to establish an infection in the epithelial cells lining the
mesenteron (midgut) (Rosen and Gubler, 1974). However, since
the mutant constructs were shown to have a delayed replication
rate in transfected C6/36 cells when compared to WT DENV2, Ae.
aegypti mosquitoes were inoculated intrathoracically (IT) so that
all the viruses would begin their replication cycle at the same
time in the parenteral tissues. Virus-containing supernatants
were derived from BHK cells transfected with WT and CCR1
mutant constructs, titered via plaque assay, and used to infect
Ae. aegypti mosquitoes IT with approximately 104 pfu/mL. All
inoculated mosquitoes showed 75–100% infection by day 20
post-inoculation by plaque assay (Fig. 5A), indicating that all
viruses were able to replicate in the parenteral tissues of Ae.
aegypti mosquitoes after IT inoculation. The mosquito bodieswere assessed for infectious virus at various timepoints (indicated
as days post-inoculation, dpi; days 5, 10 and 20) by plaque assay
(Table S1). All mutant viruses displayed a signiﬁcantly lower viral
titer than the WT at all timepoints tested, especially the ‘‘mut seq
v2’’ and ‘‘50/30 ﬂank mut’’ mutant viruses (Fig. 5B). Thus, the
replication defects observed in the in vitro experiments are
reﬂected in reduced replication in the mosquito vector for all
mutant viruses at all timepoints tested. Overall, the in vivo
infections in Ae. aegypti mosquitoes support the in vitro results
that CCR1 functions predominately as a cis-acting RNA regulatory
element, mediated in part by the 50 and 30 ﬂanking sequences.
During viral replication in the orally infected mosquito, the
virus must escape from the midgut epithelium into the hemocele
(body cavity) in order to disseminate to the brain, fat body and
salivary glands of the infected mosquito (Rosen and Gubler,
1974). Once in the salivary glands, ﬂaviviruses must undergo
Fig. 5. CCR1 modulates viral replication and dissemination to the salivary
glands in Ae. aegypti mosquitoes. (A) the rates of infection at day 20 of
colonized Panamanian Ae. aegypti mosquitoes inoculated IT with mutant
viruses. (B) Viral titers harvested from the infected mosquitoes at the indicated
timepoints, as assessed by plaque assay. (C) Salivary glands from mosquitoes
inoculated with WT and ‘‘50/30 ﬂank mut’’ mutant viruses harvested on day 10
were dissected and assayed for viral titer in Vero cells. Results were obtained from
3 independent mosquito infections. The limit of detection is shown by a dashed
line (1.4 pfu/mL). *po0.05 relative to the WT. Error bars indicate standard
deviation.
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secreted in the saliva and transmitted to a susceptible host
(Rosen and Gubler, 1974). To assess whether the replication
defects observed in vivo could affect viral dissemination in the
mosquito vector, the salivary glands were dissected from infected
mosquitoes on day 10, and viral titer was assessed by plaque
assay. Only 30% of the mosquitoes infected with the ‘‘50/30 ﬂank
mut’’ mutant viruses were found to have infected salivary glands,
as compared to 100% of the WT-infected mosquitoes (Fig. 5C). In
addition, there was a 2.6-fold decrease in the amount of virus
present in the salivary glands of the ‘‘50/30 ﬂank mut’’-infected
mosquitoes as compared to the mosquitoes infected with the WT
virus (Fig. 5C). This implies that changes to the CCR1 sequence not
only affect viral replication in the mosquito vector for up to
20 dpi, but that the effect on viral replication could have a major
impact on viral transmission by day 10 post-inoculation, though
additional experiments are necessary to determine if the replicat-
ing virus in the salivary glands is capable of being transmitted to
susceptible Ae. aegypti mosquitoes. Thus, both the in vitro and
in vivo experiments support the conclusion that CCR1 is an
important cis-acting RNA sequence element; however, the ques-
tion remains as to how it regulates the viral life cycle in both
mammalian and mosquito cells.
Mutating CCR1 has no effect on viral translation or RNA synthesis in
BHK and C6/36 cells
Most of the known RNA elements in DENV modulate the viral life
cycle by affecting translation (Alvarez et al., 2005a; Chiu et al., 2005;
Clyde and Harris, 2006) or RNA synthesis (Alvarez et al., 2005a,
2005b; Clyde et al., 2008; Filomatori et al., 2006; Friebe and Harris,
2010; Friebe et al., 2011). To determine whether the decreased viral
titers in CCR1 mutants were due to effects on either viral translation
or RNA synthesis, all mutations were subcloned into a Renilla
luciferase reporter construct, termed pDRrep (Clyde et al., 2008).
Since the ﬁrst 72 nucleotides of the capsid-coding sequence present
in the DENV2 reporter constructs contain the CCR1 sequence, it was
not necessary to introduce additional changes into pDRrep for this
study. The pDRrep-RdRpmut construct was used as a negative control
(‘‘GVD’’) because this replicon cannot replicate due to a mutation in
the active site of the RNA-dependent RNA polymerase (RdRp) (Clyde
et al., 2008). As with other DENV and WNV replicons, the replication
kinetics are slower compared to the infectious clone (Alvarez et al.,
2005a; Holden et al., 2006; Lo et al., 2003; Tilgner and Shi, 2004).
RNA transcripts were transfected into BHK and C6/36 cell mono-
layers and assayed for luciferase activity at various timepoints post-
transfection (BHK: 4, 8, 12, 24, 48 and 72 hpt; C6/36: 4, 8, 24, 72, 96,
120 and 144 hpt). None of themutant constructs showed a signiﬁcant
difference in luciferase counts at early timepoints post-transfection
when compared to the WT and GVD controls, indicating that CCR1
does not inﬂuence viral translation in BHK (Fig. 6A) or C6/36 (Fig. 6B,
left panel) cells. In BHK cells, no signiﬁcant difference in luciferase
levels was observed at later timepoints either, indicating that muta-
tions in CCR1 have no effect on RNA synthesis when compared to the
WT (Fig. 6A). Transfection of C6/36 cells with replicon RNA proved
particularly difﬁcult at later timepoints; thus, only the 24 hpt data is
shown for all mutant replicon constructs in C6/36 cells (Fig. 6B).
However, the later timepoints were achieved for the GVD negative
control and the ‘‘50/30 ﬂank mut’’ construct, which is likely represen-
tative of the other mutant constructs used in this study (Fig. 6B, right
panel). These data demonstrated that although the mutant IC con-
struct displayed reduced and delayed growth in transfected C6/36
cells (Fig. 4C), the mutant replicon produces robust levels of luciferase
activity at both early and late timepoints post-transfection when
compared to the GVD control, which indicates that viral translation
and RNA synthesis are not regulated by CCR1 in C6/36 cells (Fig. 6B,
Fig. 6. CCR1 does not affect viral translation, RNA synthesis or RNA stability in BHK cells. (A) mutations were subcloned into Renilla luciferase replicons, and the mutant
replicons were transfected into BHK cell monolayers. Left panel: Cellular lysates were harvested at the indicated timepoints and assayed for luciferase activity. An
additional mutant, termed ‘‘delta,’’ was created where the entire CCR1 sequence was removed from the replicon. Right panel: A separate graph illustrating the luciferase
levels at 4 and 72 hpt for all the mutant constructs shown in the left panel. *po0.05 relative to the WT replicon. (B) Renilla luciferase mutant replicons were transfected
into C6/36 cell monolayers. Left panel: Graph illustrating the luciferase levels at 24 hpt for all the mutant constructs, demonstrating that CCR1 mutations have no
signiﬁcant effect on viral translation. Right panel: Cellular lysates were harvested at the indicated timepoints and assayed for luciferase activity, illustrating that the CCR1
‘‘50/30 ﬂank mut’’ mutations have no effect on viral translation and RNA synthesis, whereas the negative GVD control is defective in RNA synthesis. (C) Mutations were
subcloned into a GVD variant of the IC and transfected into BHK cells. Cells were harvested at 4, 8, 24, 48 and 72 hpt, and the amount of vRNA present was quantiﬁed using
qRT-PCR in order to calculate the RNA half-life in BHK cells. Results were obtained from 3 independent experiments, conducted in duplicate. *po0.05 relative to the WT
replicon. Error bars indicate standard deviation.
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(‘‘delta’’) had no signiﬁcant effect on luciferase counts at either early
or late timepoints, implying that CCR1 is dispensable for viral
translation and replication (Fig. 6A and B, left panel). These results
imply that CCR1 inﬂuences a stage of the viral life cycle that occurs
after viral translation and RNA synthesis in mammalian andmosquito
cells, which has not yet been observed with the other known DENV
cis-acting RNA regulatory elements identiﬁed thus far.Observed effects of CCR1 mutant constructs on viral titer are not due
to RNA instability
To determine whether the introduction of silent point muta-
tions into the primary nucleotide sequence of CCR1 destabilized
the vRNA, all mutations were subcloned into a GVD variant of the
infectious clone, termed pD2/IC-RdRpmut (Clyde et al., 2008),
which is unable to replicate due to a mutation in the active site of
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within the cell after transfection, and the rate of RNA degradation
for each construct can be measured using qRT-PCR to derive the
RNA half-life, as compared to the GVD control. For all constructs
tested, none of the introduced changes signiﬁcantly altered the
RNA half-life in comparison to the GVD control (Fig. 6C). The
results derived from these stability assays are supported by the
similar translation efﬁciencies observed early after transfection
using the mutant and WT Renilla luciferase replicons in both BHK
and C6/36 cells (Fig. 6A and B). This implies that the introduced
mutations, including the deletion of the entire CCR1 sequence, do
not alter the overall stability of the RNA, or else a drop in
luciferase counts would be observed at early timepoints as a
result of decreases in the availability of the replicon RNA.
Furthermore, luciferase levels are maintained at the latest time-
points tested (72 hpt in BHK cells, 144 hpt in C6/36 cells), also
supporting the notion that the mutant replicon RNAs are as stable
as the WT. Taken together, it is likely that RNA instability is not a
cause for the observed effects of CCR1 on viral titer.CCR1 regulates infectious particle production in BHK and C6/36 cells
Though infectious virus production can be measured by plaque
assay, this does not account for non-infectious viral particles
that are routinely released during infection or infectious virions
that do not form plaques on the plaquing cell line. In order toFig. 7. CCR1 mediates infectious viral particle production. vRNA found in virus-contai
extracted at the indicated timepoints and measured by qRT-PCR. Particle:pfu ratios were
viral titers (pfu/mL) obtained at the same timepoint in IC-transfected (C) BHK or (D)
conducted in duplicate. *po0.05 relative to the WT. Error bars indicate standard devidetermine the amount of assembled viral particles in the virus-
containing supernatants from IC-transfected BHK and C6/36 cells,
the amount of vRNA was quantiﬁed using qRT-PCR. For all the
mutant constructs, there was no signiﬁcant decrease in the
amount of vRNA present in the supernatant as compared to the
WT for all the timepoints tested in BHK cells (Fig. 7A). In C6/36
cells, only the ‘‘seq mut’’ and ‘‘seq mut v2’’ constructs displayed
signiﬁcantly lower amounts of vRNA as compared to the WT
(Fig. 7B), though these levels (106 G-Eq/mL) were still high
considering that they had a no-plaque phenotype during transfec-
tions in C6/36 cells (Fig. 4C). However, the amount of vRNA
released from transfected BHK (Fig. 7A) and C6/36 cells (Fig. 7B)
was signiﬁcantly higher than the GVD control at all timepoints
tested. This result indicates that there are similar amounts of viral
particles being released from WT and mutant IC-transfected BHK
and C6/36 cells but they differ in their infectivity as determined
by plaque assay or with an immunofocus assay.
To determine the efﬁciency of infectious particle production
during transfections, the amount of vRNA present within the
virus-containing supernatants was measured using qRT-PCR and
compared to the viral titer, generating a particle-to-pfu ratio for
each mutant construct. In BHK cells, the ‘‘50/30 ﬂank mut’’
construct displayed the same particle:pfu ratio as the WT
whereas the ‘‘seq mut,’’ ‘‘seq mut v2‘‘ and ‘‘center mut’’ constructs
displayed a signiﬁcantly greater particle:pfu ratio at all time-
points tested (Fig. 7C), indicating that more non-infectious viral
particles are being released into the supernatant for thesening supernatants from IC-transfected (A) BHK or (B) C6/36 cell monolayers was
generated by comparing vRNA concentrations (G-Eq/mL) in the supernatant to the
C6/36 cell monolayers. Results were obtained from 4 independent experiments,
ation.
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lower replication kinetics in BHK cells (Fig. 4A) had a signiﬁcantly
higher particle:pfu ratio (Fig.7C). When virus-containing super-
natants derived from IC-transfected BHK cells were analyzed by
capture ELISA, both the WT and the ‘‘seq mut’’ construct displayed
equivalent amounts of viral E protein (Fig. S2, right panel).
Considering that the same samples of virus-containing super-
natants also contained similar amounts of vRNA (Fig. S2, left
panel), it is likely that cells transfected with the ‘‘seq mut’’
construct release viral particles that do not, however, form
plaques on the plaquing cell line. In C6/36 cells, both the ‘‘seqFig. 8. CCR1 has no effect on virion release or the amount of vRNA released by
BHK or C6/36 cells. The amount of extracellular infectious virus was compared to
the amount of intracellular infectious virus from IC-transfected (A) BHK and
(B) C6/36 cell monolayers at the indicated timepoints. A ratio of extra- to
intracellular virus greater than 1 was used to indicate that more virus was
released from the cells whereas a ratio of less than 1 implies that more infectious
virus is located within the cell. Results were obtained from 3 independent
experiments, conducted in duplicate. A ratio of extra- to intracellular virus of
1 is indicated by a dashed line. *po0.05 relative to the WT. Error bars indicate
standard deviation.mut’’ and ‘‘seq mut v2’’ constructs have an increased particle:pfu
ratio as compared to the WT, demonstrating that mutating the
primary sequence of CCR1 impacts infectious particle production
in both BHK and C6/36 cells (Fig. 7D), however, the amount of the
‘‘seq mut’’ mutant virus released into the supernatant was below
the limit of detection of the capture ELISA (data not shown). In
C6/36 cells, the ‘‘50/30 ﬂank mut’’ construct also showed a
signiﬁcantly higher particle:pfu ratio than the WT, indicating that
the 50/30 ﬂanking sequences contribute substantially to the
observed phenotype (Fig. 7D). In both cell types, altering the
primary nucleotide sequence of CCR1 (‘‘center mut’’ and ‘‘seq
mut’’) results in less infectious virus as compared to the WT,
though there remains the possibility that CCR1 has a structural
component in C6/36 cells. Taken together, this evidence suggests
that speciﬁc portions of the CCR1 sequence have a cell-type
dependent effect on a post-replication stage of the viral life cycle
that modulates infectious particle production.
Thus, it is likely that mutating CCR1 interferes with post-
replication events such as viral assembly, virion processing/
maturation or virion release. To examine virion release, the
amount of infectious particles outside the cell was compared to
the amount of infectious particles within cells in both BHK and
C6/36 cells. At various timepoints post-transfection (BHK: 24, 48
and 72 hpt; C6/36: 72, 96, 120 and 144 hpt), cell monolayers were
stripped of extracellular virus using a high-pH, high-salt solution
and subjected to a single freeze/thaw cycle in order to release
intracellular infectious virus, which was then assayed via plaque
assay alongside supernatants containing extracellular virus. None
of the mutant constructs showed a signiﬁcant effect on the ratio
of extra- to intracellular virus in BHK cells, except for the ‘‘seq
mut’’ and ‘‘seq mut v2’’ constructs at 24 hpt, though at this
timepoint both constructs displayed a no-plaque phenotype
(Fig. 8A). Similar observations were seen in C6/36 cells, where
those constructs capable of producing detectable infectious virus
showed no signiﬁcant retention of intracellular infectious virus as
compared to the WT (Fig. 8B). Since the decreases in viral titer are
not due to accumulation of infectious virus within the cell, it is
likely that mutating CCR1 results in a virion assembly or proces-
sing/maturation defect.Discussion
Sequence and structure conservation was used as a platform
for identifying conserved RNA regulatory elements in the DENV
coding-region, as RNA elements are more likely to perform a
function in the viral life cycle if they are conserved. Several
conserved RNA elements were selected based on their sequence
or secondary structure conservation in the DENV, JEV and TBE
serogroups. Although CCR2 and CCR3 were identiﬁed as RNA
structural elements that were conserved in the three serogroups
examined, initial screens in BHK cells showed that neither CCR2
nor CCR3 play a critical role in modulating the viral life cycle. We
found CCR1 to be conserved both in primary nucleotide sequence
and predicted secondary structure in both the DENV and TBE
serogroups and while a TBEV homolog of CCR1 has been identiﬁed
as a replication element (Rouha et al., 2011), CCR1 had not yet
been characterized for its role in regulating the DENV life cycle. In
this study, we demonstrate that DENV CCR1 functions as a cis-
acting RNA sequence element in BHK and C6/36 cells, though its
effects on viral titer and infectious virus production are more
pronounced in mosquito cells. CCR1 functions primarily through
the central sequences in BHK cells, whereas in C6/36 cells its
effects are mediated by both the 50 and 30 ﬂanking sequences as
well as the central sequences, potentially indicating a role for the
stem-loop structure of CCR1. Finally, CCR1 appears to modulate a
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viral assembly.
RNA elements that act in a cell-type speciﬁc manner can help
explain how viral replication is differentially regulated, which is
of particular relevance to understanding differences in arboviral
replication within the mammalian host and the mosquito vector.
For example, within the SIN viral genome, there is an 51-
nucleotide long conserved sequence element in the nsP1-coding
sequence that is predicted to form two smaller stem-loop struc-
tures that act as replication enhancers whose effects are more
important in mosquito cells than in mammalian cells (Fayzulin
and Frolov, 2004; Frolov et al., 2001; Niesters and Strauss, 1990).
The fact that different regions of the CCR1 sequence are impli-
cated in mediating viral replication and infectious virus produc-
tion in BHK and C6/36 cells implies the involvement of cell-type
speciﬁc factors in its function. Though CCR1 has been shown to
function as a cis-acting RNA sequence element, the fact that the
‘‘50/30 ﬂank mut’’ construct had a more severe phenotype in C6/36
cells compared to the BHK cells could imply that the predicted
secondary structure of CCR1 is more important to the viral life
cycle in mosquito cells, possibly due to the lower temperature at
which these cells are grown in vitro and in vivo. Alternatively, it is
possible that CCR1 also functions predominantly as a cis-acting
RNA sequence element in C6/36 cells and that the 50 and 30
ﬂanking sequences are more important irrespective of the pre-
dicted secondary structure. While it has been shown that CCR2
and CCR3 are not critical cis-acting RNA regulatory elements in
mammalian cells, preliminary evidence indicates that the CCR3
mutant constructs vary slightly in their ability to replicate in C6/
36 cells, which could imply that its secondary structure is not as
important as the primary nucleotide sequence (data not shown).
Interestingly, a CCR3 homolog in TBE virus has recently been
shown to act as a replication enhancer (Tuplin et al., 2011). Given
its conservation in all three ﬂavivirus serogroups examined and
the initial phenotype in C6/36 cells, it would be of interest to
introduce more speciﬁc sequence changes in CCR3, focusing on
altering the primary nucleotide sequence rather than the pre-
dicted secondary structure and testing its effects on the DENV life
cycle in C6/36 cells.
The ability to generate mutant viruses in BHK cells provided
the opportunity to determine whether the defects observed in the
in vitro experiments reﬂect the complexity of an in vivo infection
by inoculating Ae. aegypti mosquitoes. Many ﬂaviviruses exhibit a
high degree of speciﬁcity in their ability to infect and be
transmitted by arthropod species (Lindenbach et al., 2007;
Rosen et al., 1985); however, infected mosquitoes remain infec-
tious for life (1–2 weeks to 174 day) (Gubler and Kuno, 1997).
We show that mutating CCR1 not only affects viral replication
in vitro but signiﬁcantly lowers viral replication in the predomi-
nant DENV mosquito vector Ae. aegypti, providing an in vivo
model to support our in vitro data. To sustain ﬂavivirus transmis-
sion cycles in arthropods, a sufﬁcient amount of virus must be
ingested to establish an infection in the epithelial cells lining the
mesenteron (midgut) and escape into the hemocele (body cavity)
to spread to secondary ampliﬁcation tissues (Rosen and Gubler,
1974). Changes to the 50 and 30 ﬂanking sequences of CCR1
signiﬁcantly decreased viral dissemination to the salivary glands,
with a 2.6-fold decrease in the amount of virus that could be
potentially transmitted by the mosquito vector as compared to
the WT virus by day 10. This implies that altering CCR1 could
have considerable effects on viral transmission by the arthropod
vector, though more detailed studies examining the transmission
rates for all the CCR1 mutant viruses is warranted. While the data
indicate that the mutant viruses do not replicate at the same rate
as the WT once within the body cavity, it would be of interest to
investigate how well the mutant viruses can disseminate in Ae.aegypti mosquitoes when they are infected orally and virus must
infect and escape from the midgut into the body cavity.
Unlike other known RNA elements in DENV, CCR1 was shown
to have no effect on viral translation, RNA synthesis or stability in
BHK cells. It is unlikely that RNA transcripts that are shown to be
stable in one cell line would be unstable in another, so it is
improbable that the effects on viral titer and infectious particle
production observed in C6/36 cells are due to RNA instability.
Altering either the primary nucleotide sequence or the predicted
secondary structure of CCR1 had no effect on viral translation or
RNA synthesis in BHK or C6/36 cells, indicating that CCR1
functions at a post-replication stage of the viral life cycle and
supporting the notion that changes to CCR1 do not affect RNA
stability.
It is possible that CCR1 could serve as a putative assembly
signal for DENV; for instance, in retroviruses (Chadwick and
Lever, 2000; Kuno, 1997) and SIN (Frolova et al., 1997; Linger
et al., 2004; Weiss et al., 1994), the packaging signal is located
close to or within the coding-region. CCR1 does not regulate early
steps in the replication cycle such as viral translation and RNA
synthesis, and altering CCR1 results in an increased particle:pfu
ratio in BHK and C6/36 cells, demonstrating a defect in production
of infectious virions. Additionally, when virus-containing super-
natants were examined for infectivity using immunofocus assays,
the mutant constructs produced less infected cells as compared to
the WT in both BHK and C6/36 cells in a manner consistent with
the observed viral titers. However, similar amounts of vRNA and
viral E protein are released from cells transfected with WT or
CCR1 mutant constructs, indicating that viral particles are indeed
being formed but are not infectious as measured by plaque assay
and immunofocus assay. Lastly, the amount of extracellular
infectious virus is equivalent or greater to the amount of intra-
cellular infectious virus in the WT and all CCR1 mutants, indicat-
ing that mutating CCR1 does not result in the retention of virus
inside the cell. Together, these data suggest that CCR1 plays a role
in viral assembly and/or virion processing/maturation and is more
important in the mosquito vector. Our observations are consistent
with the results reported recently by Samsa et al. (2012), which
showed that mutations in this region of the capsid-coding
sequence affect infectious particle production in mammalian
and more signiﬁcantly in mosquito cells but do not impact early
replication stages of the viral life cycle. However, while the
authors attribute these effects to amino acid changes, our muta-
tions in CCR1 were silent and therefore point to the importance of
the primary nucleotide sequence rather than the amino acid
sequence of CCR1.
Flavivirus infectious particle production is achieved during
maturation in the trans Golgi compartment, where the prM
protein is cleaved into the mature M form. Although inhibiting
prM cleavage does not impair virion release, studies on prM-
containing particles suggest that furin cleavage (Stadler et al.,
1997; Wengler and Wengler, 1989) or a major structural altera-
tion in prM (Elshuber and Mandl, 2005) is required to generate
highly infectious virus. It would be of interest to determine
whether the observed effects of mutations to the CCR1 sequence
on non-infectious particle production could result from a lack of
prM cleavage due to decreased accessibility of prM to furin during
virion maturation, which could explain the overproduction of
non-infectious virions in both cell lines tested.
Many studies using electron microscopy have shown that
unlike alphaviruses, neither mature (Kuhn et al., 2002; Zhang
et al., 2003b) nor immature (Zhang et al., 2003b) ﬂavivirus
particles appear to have a capsid structure surrounding the vRNA,
resulting from a lack of icosahedral symmetry in the nucleocapsid
core (Zhang et al., 2007). The fact that there is little speciﬁc
interaction between the glycoprotein ectodomain and the capsid
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as they acquire their envelopes from the ER membrane (Zhang
et al., 2003a, 2003b). If CCR1 acts as an assembly signal, CCR1
mutations may lead to disruptions in the nucleocapsid core,
which nonetheless permit low levels of viral particle production
since ﬂaviviruses do not have a structured symmetrical nucleo-
capsid core (Zhang et al., 2007). Unfortunately, direct testing of
CCR1 interaction with the DENV capsid protein by electrophoretic
mobility shift assays was complicated by the fact that capsid
associates nonspeciﬁcally with RNA and also spontaneously forms
protein aggregates in vitro. To address viral RNA packaging, initial
analyses included transfecting RNA replicon constructs from this
study into a 293T cell line that stably expresses the DENV2 16681
structural genes (C-prM-E) in an attempt to produce DENV
Reporter Virus Particles (RVPs) (Ansarah-Sobrinho et al., 2008;
Mattia et al., 2011). However, we encountered technical difﬁcul-
ties in transfecting the replicon RNA, resulting in no Renilla
luciferase signal being detected except for the control DNA
replicon (Mattia et al., 2011). Currently, the role of CCR1 in viral
assembly is under investigation, though it is still plausible that
sequence changes to CCR1 may render the viral particles non-
infectious but not necessarily halt the assembly of viral particles.
Here we have identiﬁed a novel cis-acting regulatory RNA
sequence element located within the DENV capsid-coding
sequence, which functions in a sequence-dependent, cell-type
speciﬁc manner to regulate post-RNA replication production of
infectious viral particles. Whether CCR1 serves as a putative
assembly signal for DENV is still under investigation. Studies
such as these provide evidence that RNA elements located within
the coding-region can have diverse roles in regulating distinct
stages within the viral life cycle in the mammalian host and
mosquito vector. In addition, the identiﬁcation of mutations
affecting late steps in DENV replication should yield valuable
information about the ﬁnal stages in the viral life cycle, which are
still poorly understood. The observation that CCR1 is more
important in the mosquito vector both in vitro and in vivo allows
for exploration into viral replication strategies in mosquito cells
and the requirements for efﬁcient viral transmission. Finally,
conserved cis-acting RNA elements in the coding-region could
serve as targets for novel therapeutics since development of
resistance is constrained by both their RNA regulatory function
and amino acid coding capacity.Materials and methods
Sequence conservation and secondary structure prediction
algorithms
For conserved sequence prediction, sequences were aligned
using the Clustal W2 web software (Thompson et al., 1997) from
the European Bioinformatics Institute. Portions of the Clustal W2
alignments were processed by the RNAalifold web server
(Hofacker et al., 2002) from the Institute of Theoretical Chemistry
at the University of Vienna to generate phylogenetically con-
served secondary structure predictions. Individual RNA secondary
structures were predicted using the mfold3 web server (Zuker,
2003) from the RNA Institute at the University at Albany.
Reported DG values reﬂect enf reﬁnement, the mfold free-energy
computation incorporating coaxial stacking and the Jacobson–
Stockmeyer theory for multibranched loops (Zuker, 2003).
Construction of mutant DNA constructs
Mutations were introduced into the capsid-coding region
of an infectious clone (IC) of the DENV-2 Thai strain 16681(pD2/IC-30P, hereafter pD2/IC; a gift from R. Kinney, Centers for
Disease Control and Prevention, Fort Collins, CO) using splicing
overlap extension-PCR (SOE-PCR), where the T7 promoter and the
ﬁrst 1391 nucleotides (nts) of DENV-2 were ampliﬁed. Resulting
products were digested with SacI/SphI and ligated into a SacI/
SphI-digested pD2/IC or a SacI/SphI-digested pD2/IC-RdRpmut
(‘‘GVD’’), as previously described (Clyde et al., 2008; Clyde and
Harris, 2006). For the Renilla luciferase reporter constructs, the T7
promoter and the ﬁrst 167 nts from the IC constructs were
ampliﬁed, and resulting products were digested with NotI/MluI
and ligated into a NotI/MluI-digested pDRrep as previously
described (Clyde et al., 2008). For the ‘‘delta’’ replicon, CCR1 was
removed from pDRrep using SOE-PCR. Primer sequences are
available upon request.Generation of RNA templates
For all DNA templates (pD2/IC, pD2/IC-RdRpmut, pDRrep and
pDRrep-RdRpmut), linearized templates were generated by diges-
tion with XbaI and puriﬁed using a 25:24:1 phenol/chloroform/
isoamyl alcohol extraction (pH 6.770.2, Fischer Scientiﬁc). RNA
templates were generated via in vitro transcription using the
RiboMax Large Scale RNA Production System (T7, Promega) with
the following modiﬁcations to the manufacturer’s protocol: 5 mM
each GTP, CTP and UTP; 1 mM ATP; and 5 mM m7G(50)ppp(50)A
cap analog (New England Biolabs) were incubated for 4 h at 30 1C
with the addition of 2 mM ATP after 30 min. RNAs were subse-
quently treated with 80 U/mL TURBO DNase (Ambion) for 15 min
at 37 1C, and unincorporated nucleotides were removed from
DENV RNAs by size exclusion chromatography using Micro
Bio-Spin P-30 Tris columns (BioRad Laboratories).Cell culture
Baby hamster kidney cells (BHK-21, clone 15; hereafter BHK)
were grown in minimal essential medium-alpha (MEMa, Gibco)
with 5% fetal bovine serum (FBS; HyClone) at 37 1C in 5% CO2.
A high temperature (HT) variant (gift from A. Garmanik, Funda-
cio´n Instituto Leloir, Buenos Aires, Argentina) was utilized for
transfection in Ae. albopictus mosquito cells (C6/36), which were
grown in Leibovitz’s medium (L-15, Gibco) with 10% FBS at 33 1C
without CO2. All media was supplemented with 10 mM HEPES
(pH 7.5), 100 units/mL penicillin, and 100 mg/mL streptomycin.RNA transfections
BHK cells were seeded in 24-well plates, grown to 50%
conﬂuence, and transfected with 0.5 mg IC or replicon RNA using
4 Lipofectamine 2000 (Invitrogen), followed by a 2-h incuba-
tion at 37 1C in 5% CO2. BHK cells were washed 3 in MEMa
medium and incubated at 37 1C with 5% CO2 until harvest at
indicated timepoints. C6/36 HT cells were seeded in 12-well
plates, grown to 95% conﬂuence, and transfected with 1 mg IC or
replicon RNA using 6 Lipofectamine 2000 (Invitrogen), followed
by a 3-h incubation at 33 1C without CO2. C6/36 HT cells were
washed 1 in L-15 media and incubated at 33 1C without CO2
until harvest at indicated timepoints. Virus-containing super-
natants and intracellular virus were collected, so that viral titer
could be assessed by plaque assay. Cellular RNA was harvested
from a duplicate well and puriﬁed using the Mini RNA Isolation II
Kit (Zymo Research), and viral RNA (vRNA) concentrations were
determined using quantitative reverse transcriptase (qRT)-PCR.
vRNA in the virus-containing supernatants was isolated using the
ZR Viral RNA kit (Zymo Research) and quantiﬁed using qRT-PCR.
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Plaque assays using BHK cells for virus titration were con-
ducted as described previously (Clyde et al., 2008; Clyde and
Harris, 2006; Diamond et al., 2000). The viral titers in Ae. aegypti
mosquito bodies and salivary glands were determined by plaque
assay on African green monkey kidney cells (Vero, ATCC #CCL-81)
as previously described (Payne et al., 2006). Viral titer was
calculated as plaque forming units (pfu) per mL, and the limit of
detection was deﬁned as the lowest titer of virus that could be
accurately measured in BHK (1.9 pfu/mL) and Vero (1.4 pfu/mL)
cells. For transfections, viral titers were normalized to the amount
of vRNA in the cells at the time that the virus-containing super-
natants were harvested, as determined by qRT-PCR. p-values
relative to the WT control were derived by Wilcoxon rank sum
test in Mstat.
Quantitative RT-PCR
qRT-PCR was performed using a modiﬁcation to the method of
Laue et al. (1999), which uses a FAM-TAMRA labeled probe and
primer set that is directed to the viral NS5 gene. The TaqMan One-
Step Master Mix (Applied Biosystems) system was used with the
following modiﬁcations to the protocol: the RT step was con-
ducted at 48 1C for 30 min, the initial denaturation step was
performed at 95 1C for 10 min, the annealing temperature was set
at 60 1C, and the reaction volume was ﬁxed at 20 mL. For the
purposes of determining transfection efﬁciency, target vRNA was
ﬁrst normalized to the cellular 18S RNA using the TaqMan
VIC-MGB Primer Limited Eukaryotic 18S rRNA Endogenous
Control (Applied Biosystems) in a parallel reaction. qRT-PCR
was conducted on a Sequence Detection System 7300 (Applied
Biosystems).
Ae. aegypti mosquitoes
The Ae. aegypti colony originated from eggs collected in
Panama by J. Loaiza and were received at the Arbovirus Labora-
tory (Wadsworth Center) in 2007. Colonized mosquitoes were
maintained on deﬁbrinated rabbit blood with 10% sucrose (for egg
laying) and given 10% sucrose ad libitum. Larvae were reared and
adults maintained at 27 1C with 70% relative humidity (RH) and
under a 16:8 light:dark diurnal cycle in 30.5-cm3 cages.
Infection of Ae. aegypti mosquitoes
Virus-containing supernatants were harvested at 72 h post-
transfection (hpt) from IC-transfected BHK cells. Virus-containing
supernatants were concentrated by ultracentrifugation at 89,500g
for 2-h using a 5% cold sucrose column, and viral titer was
assessed by plaque assay. Viruses were diluted to a titer of
104 pfu/mL in mosquito diluent (MD; 20% heat-inactivated FBS
in PBS (Dulbecco) supplemented with 50 mg/mL penicillin/strep-
tomycin, 50 mg/mL gentamicin, and 2.5 mg/mL fungizone). Two-
to-ﬁve day-old mosquitoes were inoculated intrathoracically (IT)
with 0.1–1 pfu under CO2 anesthesia using the FemtoJet micro-
injection system (Eppendorf) and held at 30 1C with a 16:8
light:dark photoperiod for up to 20-day post-inoculation (dpi).
Mosquito bodies were placed into 1 mL MD, and samples were
stored at 70 1C until they were homogenized in a mixer mill
(Qiagen) and clariﬁed by centrifugation at 1200 rpm for 3 min.
Body titer was evaluated at indicated timepoints, and the viral
load in infected mosquitoes was determined by plaque assay.
Salivary glands were dissected from infected mosquitoes on day
10 post-inoculation and placed into 0.3 mL MD, while the mos-
quito remnants were placed in 1 mL MD; samples were stored at70 1C. Viral load in the salivary glands was determined by
plaque assay.
Luciferase assay
BHK and C6/36 HT cells were transfected with the Renilla
luciferase reporter constructs and harvested at the indicated
timepoints. Samples were analyzed with the Renilla Luciferase
Assay System (Promega) according to the manufacturer’s instruc-
tions on a GloMax-96 Microplate Luminometer (Promega) with
the following modiﬁcations: 50 mL cell lysate and 40 mL of
1Renilla Luciferase Assay Substrate was used for each sample.
Luciferase activity levels were normalized to the relative transfec-
tion efﬁciency at 2 hpt as determined by qRT-PCR. p-values
relative to the WT control were derived by Wilcoxon rank sum
test in Mstat.
Determination of vRNA half-life
Total cellular RNA was harvested from BHK cells transfected
with pD2/IC-RdRp constructs (‘‘GVD’’) at 2, 4, 8, 24, 48 and 72 hpt,
treated with DNase, and quantiﬁed by NS5 qRT-PCR as described
above. Values were graphed, and an exponential trendline was
ﬁtted to the data in Microsoft Excel 2007. The half-life of each
variant in each experiment was determined from the exponential
trendline equation, averaged and shown in Fig. 5C. p-values
relative to the GVD control were derived by Wilcoxon rank sum
test in Mstat.
Intracellular virus extraction
Virus-containing supernatants were harvested from IC-trans-
fected BHK and C6/36 HT cell monolayers at indicated timepoints
and assessed by plaque assay to determine the extracellular viral
titers. To obtain the intracellular viral titers, cells were washed
1 in PBS and then incubated for 3 min at 4 1C with an alkaline/
high-salt solution of 1 M NaCl plus 50 mM sodium bicarbonate,
pH 9.5, to remove the surface-bound virus (Diamond and Harris,
2001; Helt and Harris, 2005). Cells were washed 2 in PBS before
the addition of 0.25% Trypsin-EDTA (Gibco) to detach cells from
the plates. Cells were harvested in MEMa (BHK) or L-15 (C6/36)
medium and lysed during a single freeze–thaw cycle. Cellular
debris was pelleted by centrifugation at 3200g for 5 min, and the
intracellular virus-containing supernatant was removed and
assessed for viral titer by plaque assay. Extra- vs. intracellular
viral concentrations were calculated as ratios, where a ratio
greater than one indicates that there was no accumulation of
infectious virus within the cell and ratios less than one indicates
that there was more intracellular infectious virus than what was
being released into the supernatant. p-values relative to the WT
control were derived by Wilcoxon rank sum test in Mstat.
Statistical analysis
Wilcoxon rank sum test were performed in Mstat. Statistical
signiﬁcance was deﬁned as po0.05.Acknowledgments
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